PH31439A - Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol. - Google Patents
Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol.Info
- Publication number
- PH31439A PH31439A PH49098A PH49098A PH31439A PH 31439 A PH31439 A PH 31439A PH 49098 A PH49098 A PH 49098A PH 49098 A PH49098 A PH 49098A PH 31439 A PH31439 A PH 31439A
- Authority
- PH
- Philippines
- Prior art keywords
- cholecalciferol
- ene
- dihydroxy
- stable
- active metabolites
- Prior art date
Links
- 239000011647 vitamin D3 Substances 0.000 title abstract 6
- 229940021056 vitamin d3 Drugs 0.000 title abstract 6
- 239000002207 metabolite Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000009877 rendering Methods 0.000 abstract 2
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 210000002510 keratinocyte Anatomy 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/131,264 US5401733A (en) | 1993-10-01 | 1993-10-01 | Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH31439A true PH31439A (en) | 1998-11-03 |
Family
ID=22448675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH49098A PH31439A (en) | 1993-10-01 | 1994-09-30 | Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5401733A (da) |
| EP (1) | EP0646576B1 (da) |
| JP (1) | JP2677520B2 (da) |
| CN (1) | CN1041201C (da) |
| AT (1) | ATE162786T1 (da) |
| AU (1) | AU683917B2 (da) |
| CA (1) | CA2133144C (da) |
| DE (1) | DE69408244T2 (da) |
| DK (1) | DK0646576T3 (da) |
| ES (1) | ES2113020T3 (da) |
| GR (1) | GR3026154T3 (da) |
| NZ (1) | NZ264537A (da) |
| PH (1) | PH31439A (da) |
| RU (1) | RU2133738C1 (da) |
| ZA (1) | ZA947453B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9524812D0 (en) * | 1995-12-05 | 1996-02-07 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9625271D0 (en) * | 1996-12-04 | 1997-01-22 | Leo Pharm Prod Ltd | Chemical compounds |
| KR20050123185A (ko) * | 1996-12-20 | 2005-12-29 | 쥬가이 세이야쿠 가부시키가이샤 | 16-엔-비타민 d 유도체 |
| JPH10316652A (ja) * | 1997-05-02 | 1998-12-02 | Duphar Internatl Res Bv | 16−デヒドロビタミンd化合物の製造方法 |
| CA2289209C (en) | 1997-05-16 | 2006-07-25 | Women & Infants Hospital | Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof |
| DE69834109T2 (de) * | 1997-05-16 | 2007-04-19 | Woman & Infants Hospital | 3-epi-vitamin d2 verbindungen und ihre anwendungen |
| WO1999011272A1 (en) * | 1997-09-02 | 1999-03-11 | Johns Hopkins University School Of Medicine | Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders |
| US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| JP2004292314A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4617297A (en) * | 1982-02-12 | 1986-10-14 | Hoffmann-La Roche Inc. | Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol |
| US4594432A (en) * | 1983-01-28 | 1986-06-10 | Hoffman-La Roche Inc. | Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol |
| US4501738A (en) * | 1983-06-30 | 1985-02-26 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases |
| US4495181A (en) * | 1983-10-03 | 1985-01-22 | The Regents Of The University Of California | 1,25-Dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3 |
| US4719205A (en) * | 1984-01-30 | 1988-01-12 | Wisconsin Alumini Research Foundation | Side-chain unsaturated 1-hydroxyvitamin D compounds |
| JPS6144860A (ja) * | 1984-08-10 | 1986-03-04 | Taisho Pharmaceut Co Ltd | 1α.25−ジヒドロキシ−26.27−ジメチルビタミンD↓3 |
| JPS61129130A (ja) * | 1984-11-27 | 1986-06-17 | Kureha Chem Ind Co Ltd | 抗尿毒症剤 |
| US4612308A (en) * | 1984-11-29 | 1986-09-16 | Hoffmann-La Roche Inc. | 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers |
| ATE45347T1 (de) * | 1985-05-30 | 1989-08-15 | Taisho Pharmaceutical Co Ltd | Vitamin d3-derivate. |
| WO1987003282A1 (fr) * | 1985-11-21 | 1987-06-04 | Taisho Pharmaceutical Co., Ltd. | Derive de la vitamine d3 |
| JPS6391323A (ja) * | 1986-10-03 | 1988-04-22 | Kureha Chem Ind Co Ltd | 抗尿路結石症剤 |
| US5001118A (en) * | 1986-12-29 | 1991-03-19 | Kureha Kagaku Kogyo Kabushiki Kaisha | Method for preventing senescence and increasing bone mass |
| ZA8923B (en) * | 1988-01-20 | 1989-09-27 | Hoffmann La Roche | 16-dehydro-vitamin d3-derivatives |
| US5087619A (en) * | 1988-01-20 | 1992-02-11 | Hoffman-La Roche Inc. | Vitamin D3 analogs |
| US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
| US5145846A (en) * | 1988-01-20 | 1992-09-08 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| US4851401A (en) * | 1988-07-14 | 1989-07-25 | Wisconsin Alumni Research Foundation | Novel cyclopentano-vitamin D analogs |
| GB8915770D0 (en) * | 1989-07-10 | 1989-08-31 | Leo Pharm Prod Ltd | Chemical compounds |
| US5260290A (en) * | 1990-02-14 | 1993-11-09 | Wisconsin Alumni Research Foundation | Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives |
| DE4011682A1 (de) * | 1990-04-06 | 1991-10-10 | Schering Ag | 24-oxa-derivate in der vitamin d-reihe |
| US5200536A (en) * | 1992-02-10 | 1993-04-06 | Daikin Industries Ltd. | Fluorine-containing vitamin D3 analogues |
| US5194431A (en) * | 1992-07-08 | 1993-03-16 | Wisconsin Alumni Research Foundation | 24-cyclopropane vitamin D derivatives |
-
1993
- 1993-10-01 US US08/131,264 patent/US5401733A/en not_active Expired - Lifetime
-
1994
- 1994-09-17 AT AT94114668T patent/ATE162786T1/de not_active IP Right Cessation
- 1994-09-17 DE DE69408244T patent/DE69408244T2/de not_active Expired - Fee Related
- 1994-09-17 ES ES94114668T patent/ES2113020T3/es not_active Expired - Lifetime
- 1994-09-17 DK DK94114668T patent/DK0646576T3/da active
- 1994-09-17 EP EP94114668A patent/EP0646576B1/en not_active Expired - Lifetime
- 1994-09-23 ZA ZA947453A patent/ZA947453B/xx unknown
- 1994-09-26 NZ NZ264537A patent/NZ264537A/en unknown
- 1994-09-26 AU AU74225/94A patent/AU683917B2/en not_active Ceased
- 1994-09-27 RU RU94035663A patent/RU2133738C1/ru not_active IP Right Cessation
- 1994-09-27 JP JP6231094A patent/JP2677520B2/ja not_active Expired - Fee Related
- 1994-09-28 CN CN94116578A patent/CN1041201C/zh not_active Expired - Fee Related
- 1994-09-28 CA CA002133144A patent/CA2133144C/en not_active Expired - Fee Related
- 1994-09-30 PH PH49098A patent/PH31439A/en unknown
-
1998
- 1998-02-17 GR GR980400329T patent/GR3026154T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU94035663A (ru) | 1996-07-20 |
| JP2677520B2 (ja) | 1997-11-17 |
| ES2113020T3 (es) | 1998-04-16 |
| DE69408244D1 (de) | 1998-03-05 |
| EP0646576A1 (en) | 1995-04-05 |
| NZ264537A (en) | 1996-05-28 |
| CN1106384A (zh) | 1995-08-09 |
| CN1041201C (zh) | 1998-12-16 |
| CA2133144C (en) | 2005-05-24 |
| CA2133144A1 (en) | 1995-04-02 |
| ATE162786T1 (de) | 1998-02-15 |
| DK0646576T3 (da) | 1998-09-23 |
| EP0646576B1 (en) | 1998-01-28 |
| JPH07179418A (ja) | 1995-07-18 |
| AU683917B2 (en) | 1997-11-27 |
| RU2133738C1 (ru) | 1999-07-27 |
| US5401733A (en) | 1995-03-28 |
| AU7422594A (en) | 1995-04-13 |
| GR3026154T3 (en) | 1998-05-29 |
| DE69408244T2 (de) | 1998-08-27 |
| ZA947453B (en) | 1995-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE122006000018I2 (de) | 19-Nor-Vitamin-D-Derivate. | |
| AU2118488A (en) | Improvements in or relating to methods of treating damaged skin | |
| SG52320A1 (en) | Novel (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans | |
| PH24969A (en) | Insecticidal pyrazolines | |
| PH31439A (en) | Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol. | |
| DE60018554D1 (de) | Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten | |
| ZA955826B (en) | Dinucleoside-5',5'pyrophosphates | |
| BG101126A (en) | The use of muramylpeptide compounds | |
| BG103260A (en) | The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis | |
| MY103593A (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
| ES8302634A1 (es) | Procedimiento de preparacion de derivados del acido metilen-2-succinamico | |
| JPS5753475A (en) | Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same | |
| ZA873928B (en) | Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease | |
| IL57609A (en) | Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids | |
| EP0551844A3 (da) | ||
| HK64993A (en) | Therapeutic agent for the treatment of disorders associated with cerebral ischemia | |
| IE830308L (en) | Selective herbicidals | |
| IT1244459B (it) | Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi | |
| GR3024709T3 (en) | Novel cytarabine derivatives, their production and use | |
| RU95100512A (ru) | Мазь для лечения кожных заболеваний |